Type 2 Diabetes, Obesity and Cortisol Excess
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorIstituto Auxologico Italiano
About this trial
The present observational cross-sectional study is aimed to assess: the hidden hypercortisolism (HidHyCo) prevalence in a sample of Type 2 diabetes (T2D) patients and the clinical characteristics more frequently associated with the HidHyCo presence and the HidHyCo prevalence in an adequate sample of obese patients without T2D and the clinical characteristics more frequently associated with the HidHyCo presence.
Eligibility criteria
Qualifiers
None
Disqualifiers
pregnancy/breast feeding,
sleep apnea,
prepuberal onset of hypertension, hormonal hypersecreting adrenal mass,
symptoms of hypercortisolism;
Trial design
Treatments tested in this trial
- 1mg DST
Treatment groups
3,200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Istituto Auxologico Italiano
Lead sponsor
University of Siena
Collaborator
Niguarda Hospital
Collaborator
Campus Bio-Medico University
Collaborator
Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy
Collaborator
Source ClinicalTrials.gov